Klisyri 10 mg/g ointment clinical trials
4 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
Exploratory pilot study to determine the tolerability and effectiveness of Tirbanibulin in the treatment of Actinic Cheilitis
Researchers are testing a new cream called Klisyri for a lip condition called Actinic Cheilitis. This early study looks at how well the cream works and if it's safe to use to heal the condition.
For: Actinic CheilitisGermany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multicentre, Randomised, Double-blind, Vehicle-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Tirbanibulin 10 mg/g Ointment Applied to a Treatment Field Larger Than 25 cm2 and up to 100 cm2 in Adult Patients With Actinic Keratosis
This study is testing a special ointment called Tirbanibulin for adults with a common sun-related skin condition called actinic keratosis on their face or scalp. It's looking at how well the ointment clears up the skin and if it's safe to use.
For: Actinic Keratosis on the Face or ScalpSpain · Netherlands · Poland - Ongoing, recruitingPhase III and phase IV (Integrated)
Clinical efficacy and safety of sequential therapy with cryotherapy and topical tirbanibulin 1% in actinic keratoses in transplant recipients: a randomised clinical trial.
This study looks at a skin condition called actinic keratosis in people who have had organ transplants. It compares a treatment that combines freezing therapy with a cream called Klisyri to freezing therapy alone, to see which is better at clearing these skin spots.
For: Actinic keratosisSpain - AuthorisedPhase III and phase IV (Integrated)
Efficacy and Safety of Cryotherapy followed by Tirbanibulin ointment for actinic keratosis on the scalp and forehead
This study is looking at a new way to treat rough, scaly patches on the scalp and forehead called actinic keratosis. It combines freezing therapy with a special ointment to see how well it works and if it's safe for people over 18.
For: Patients (male or female) ≥18 years old with scalp and forehead actinic keratosesFrance